Genitourinary Oncology Committee of Chinese Anti-Cancer Association (CACA-GO) guideline for prostate cancer for patients (2025 edition)

Prostate cancer is a relatively common malignant tumor in the genitourinary system of elderly men, posing a heavy burden to the public health. In order to disseminate the knowledge of early screening and diagnosis of prostate cancer, effectively promote the prevention and treatment of prostate cancer in China, and improve patients' cognition of prostate cancer,the Genitourinary Oncology Committee of Chinese Anti-Cancer Association organized a panel of experts to formulate the "Genitourinary Oncology Committee of China Anti-Cancer Association (CACA-GO) guideline for prostate cancer for patients (2025 edition)", with the aim of enhancing the understanding of prostate cancer diagnosis and treatment among patients and their families, assisting clinicians in more effectively conducting prostate cancer diagnosis and treatment, thereby improving patients' survival outcomes and quality of life, benefiting more prostate cancer patients, and contributing to the grand goal of "Healthy China 2030".

前列腺癌是老年男性泌尿生殖系统较为常见的恶性肿瘤，给国民健康带来了严峻挑战。为加大前列腺癌早筛早诊相关知识的普及力度，切实推动中国前列腺癌防治事业进展，提升患者对于前列腺癌诊疗的认知，中国抗癌协会男性生殖系统肿瘤专业委员会组织国内泌尿肿瘤领域权威专家，充分借鉴国内外前列腺癌诊疗指南、最新临床研究进展，深度结合中国国情和患者需求，共同编撰了《中国抗癌协会男性生殖系统肿瘤专业委员会前列腺癌指南患者版（2025版）》。指南旨在全方位增进患者及其家属对前列腺癌诊疗的认知程度，辅助临床医师更出色地开展前列腺癌的诊断及治疗工作，进而改善患者生存结局及生活质量，惠及更多前列腺癌患者，助力达成“健康中国2030”的宏大目标。.